Nelson RM - Search Results

1

The Food and Drug Administration's Federal Review of a Pediatric Muscular Dystrophy Protocol.

Snyder DL, Nelson RM. Snyder DL, et al. Among authors: nelson rm. IRB. 2018 Jan-Feb;40(1):18-20. IRB. 2018. PMID: 29910527 Free PMC article. No abstract available.

2

A Framework for Evaluating a Minor's Involvement in Medical Decision Making.

Snyder DL, Nelson RM. Snyder DL, et al. Among authors: nelson rm. Am J Bioeth. 2018 Mar;18(3):10-12. doi: 10.1080/15265161.2017.1418938. Am J Bioeth. 2018. PMID: 29466124 Free PMC article. No abstract available.

3

Inclusion of Adolescents in Adult Clinical Trials: Report of the Institute for Advanced Clinical Trials for Children's Pediatric Innovation Research Forum.

Noel GJ, Nelson RM, Bucci-Rechtweg C, Portman R, Miller T, Green DJ, Snyder D, Moreno C, Hovinga C, Connor E. Noel GJ, et al. Among authors: nelson rm. Ther Innov Regul Sci. 2021 Jul;55(4):773-778. doi: 10.1007/s43441-021-00283-y. Epub 2021 Apr 2. Ther Innov Regul Sci. 2021. PMID: 33811302 Free PMC article.

4

Informed consent for genetic research involving pleiotropic genes: an empirical study of ApoE research.

Cooper ZN, Nelson RM, Ross LF. Cooper ZN, et al. Among authors: nelson rm. IRB. 2006 Sep-Oct;28(5):1-11. IRB. 2006. PMID: 17152129 No abstract available.

5

Food and Drug Administration public hearing on the conduct of emergency clinical research: testimony of Dr. Nelson.

Nelson RM. Nelson RM. Acad Emerg Med. 2007 Apr;14(4):e43-4. doi: 10.1197/j.aem.2006.11.026. Epub 2007 Feb 25. Acad Emerg Med. 2007. PMID: 17322567 Free article. No abstract available.

6

Ethical considerations in conducting pediatric research.

Roth-Cline M, Gerson J, Bright P, Lee CS, Nelson RM. Roth-Cline M, et al. Among authors: nelson rm. Handb Exp Pharmacol. 2011;205:219-44. doi: 10.1007/978-3-642-20195-0_11. Handb Exp Pharmacol. 2011. PMID: 21882114

7

Institutional review boards lack the moral legitimacy to reinterpret subpart D.

Nelson RM. Nelson RM. Am J Bioeth. 2008 Apr;8(4):37-9. doi: 10.1080/15265160802147264. Am J Bioeth. 2008. PMID: 18576252 No abstract available.

8

Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn.

Komatsu Y, Verweij EJTJ, Tiblad E, Lopriore E, Oepkes D, Agarwal P, Lam E, Leu JH, Ling LE, Nelson RM, Olusajo V, Saeed-Khawaja S, Tjoa ML, Zhou J, Amin U, Sirah W, Moise KJ. Komatsu Y, et al. Among authors: nelson rm. Am J Perinatol. 2024 Sep 17. doi: 10.1055/a-2404-8089. Online ahead of print. Am J Perinatol. 2024. PMID: 39197469 Free article.

9

A Benefit-Risk Conceptual Framework for Biologic Use During Pregnancy: A Mini-Review.

Bozzi LM, Jacobson MH, Yost E, Sheahan A, Cafone J, Komatsu Y, Schwartz L, Levitan B, Nelson RM. Bozzi LM, et al. Among authors: nelson rm. Clin Pharmacol Ther. 2024 Jun;115(6):1251-1257. doi: 10.1002/cpt.3239. Epub 2024 Mar 20. Clin Pharmacol Ther. 2024. PMID: 38506485 Review.

10

Neuropsychiatric Manifestations of Mast Cell Activation Syndrome and Response to Mast-Cell-Directed Treatment: A Case Series.

Weinstock LB, Nelson RM, Blitshteyn S. Weinstock LB, et al. Among authors: nelson rm. J Pers Med. 2023 Oct 31;13(11):1562. doi: 10.3390/jpm13111562. J Pers Med. 2023. PMID: 38003876 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters